MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Colorectal Cancer Treatments and Studies
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,073 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,073 works in the cohort · of 4,299,418page 1 of 22

Labels cover 5 of 1,073 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,073 of 1,073 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Cetuximab for the Treatment of Colorectal Cancer
Derek J. Jonker, Chris J. O’Callaghan, Christos S. Karapetis, John Zalcberg, Dongsheng Tu, Scott Berry +7 more
2007· article· en· New England Journal of Medicine· Medicine
distilled prediction:candidate · noneconsensus · none
1,806
citations
affunlabeled
Capecitabine as Adjuvant Treatment for Stage III Colon Cancer
Chris Twelves, A. Wong, Marek P. Nowacki, Markus Abt, Howard A. Burris, Alfredo Carrato +20 more
2005· article· en· New England Journal of Medicine· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
1,247
citations
affno abstractunlabeled
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study
Josep Tabernero, Takayuki Yoshino, Allen Lee Cohn, Radka Obermannová, G. Bodoky, Rocio García‐Carbonero +13 more
2015· article· en· The Lancet Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
955
citations
affunlabeled
Phase III Trial Comparing 4-Day Chronomodulated Therapy Versus 2-Day Conventional Delivery of Fluorouracil, Leucovorin, and Oxaliplatin As First-Line Chemotherapy of Metastatic Colorectal Cancer: The European Organisation for Research and Treatment of Cancer Chronotherapy Group
Sylvie Giacchetti, Georg A. Bjarnason, Carlo Garufi, Dominique Genet, Stefano Iacobelli, Marco Tampellini +14 more
2006· article· en· Journal of Clinical Oncology· Medicine
distilled prediction:candidate · noneconsensus · none
227
citations
next →

How this was built: Screen · Findings · About